Stay updated with breaking news from Avedro Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Automated Visual Field Analyzer Market Research Report by Product Type, by End-use, by Region - Global Forecast to 2027 - Cumulative...
/PRNewswire/ -- The "Eye Care Surgical Market Research Report by Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19"...
/PRNewswire/ -- The "Eye Care Surgical Market Research Report by Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19"...
Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced... | May 5, 2021
Search jobs Glaukos Corporation Announces First Quarter 2021 Financial Results SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2021. Key highlights include: Net sales growth of 23% to $68.0 million in Q1 2021, compared to $55.3 million in Q1 2020. Glaucoma net sales of $53.7 million and Corneal Health net sales of $14...